PCP had a large amount of capital sales for RAH - infusion $4.4M ADAPT $1.6M = $6M
Infusion consumables is said to be around $1M a month - a little higher now RAH is open
I see total revenue at $6.5M - $3M ADAPT $3.5M infusion
Cash burn $2M as no tax rebate
My guess DYOR
Quarterly report - ADAPT sales, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.56 |
Change
-0.740(5.56%) |
Mkt cap ! $265.4M | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.30 | $12.55 | $359.0K | 27.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 399 | $12.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.78 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |